A Pragmatic Randomized Controlled Trial to Evaluate the Efficacy and Safety of an Oral Short-course Regimen Including Bedaquiline for the Treatment of Patients With Multidrug-resistant Tuberculosis in China
Latest Information Update: 20 Jan 2023
At a glance
- Drugs Bedaquiline (Primary) ; Clofazimine (Primary) ; Cycloserine (Primary) ; Levofloxacin (Primary) ; Linezolid (Primary) ; Protionamide (Primary) ; Pyrazinamide (Primary)
- Indications Pulmonary tuberculosis
- Focus Therapeutic Use
- Acronyms PROSPECT
Most Recent Events
- 20 Jan 2023 Last checked against ClinicalTrials.gov record.
- 24 Jun 2022 Status changed from not yet recruiting to recruiting.
- 07 Apr 2022 New trial record